Researchers in Israel have conducted a study showing that the immunity provided against severe acute…
View More Prior SARS-CoV-2 infection and Pfizer-BioNTech’s COVID-19 vaccine provide similar immunityHome » SARS-CoV-2 »
B.1.1.7 variant 45% more infectious than wild-type SARS-CoV-2, but can be effectively contained by BNT162b2 vaccine
The SARS-CoV-2 B.1.1.7 variant, also called the UK variant, was identified in London as well…
View More B.1.1.7 variant 45% more infectious than wild-type SARS-CoV-2, but can be effectively contained by BNT162b2 vaccineAntibodies may not inhibit SARS-COV-2 variants from mink
It has been known for about a year that minks can become infected with SARS-CoV-2.…
View More Antibodies may not inhibit SARS-COV-2 variants from minkStudy highlights the importance of mask fit when double masking to protect against COVID-19
A study published today in JAMA Internal Medicine shows that wearing two face coverings can…
View More Study highlights the importance of mask fit when double masking to protect against COVID-19High antibody and inflammatory mediator levels may predict severe COVID-19
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),…
View More High antibody and inflammatory mediator levels may predict severe COVID-19Real-world evidence from Israel on VOCs and SARS-CoV-2 vaccine protection
A new study by Israeli researchers tested the hypothesis that certain SARS-CoV-2 variants of concern…
View More Real-world evidence from Israel on VOCs and SARS-CoV-2 vaccine protectionResearchers discover a new monoclonal antibody that is effective against SARS-CoV-2 variants
A new monoclonal antibody targets a particular region of the receptor-binding domain (RBD) on the…
View More Researchers discover a new monoclonal antibody that is effective against SARS-CoV-2 variantsChildren and SARS-CoV-2: More infections than reported cases during second wave in Germany
The prevalence of SARS-CoV-2 infections in preschool and school children is an important benchmark for…
View More Children and SARS-CoV-2: More infections than reported cases during second wave in GermanyNew mRNA COVID-19 vaccine candidate shows promise in vivo
Researchers report that a new lipid nanoparticle mRNA coronavirus disease 2019 (COVID-19) vaccine candidate protected…
View More New mRNA COVID-19 vaccine candidate shows promise in vivoLinear epitope mapping of the SARS-CoV-2 spike protein
The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been the primary…
View More Linear epitope mapping of the SARS-CoV-2 spike protein